$INKT

$10.20▲ +1.5% YTD

4 SEC 13D/G filings tracked · Last updated Nov 6, 2026

Filing History

CP $10.20▲ +1.5%Nov 6, 2026 · ThinkSabio Blog

$INKT - MiNK Therapeutics New Data Highlights Its Off-the-Shelf iNKT Cell Therapy Targets Two Key Mechanisms of Tumor Resistance Presented at the Soci…

News

INKT ▲ +5.6% - MiNK Therapeutics, Inc.

CP $11.04▲ +5.6%Nov 2, 2026 · ThinkSabio Blog

$INKT - MiNK Therapeutics to Report Third Quarter 2026 Results and Outline Progress in Randomized Clinical Development and Scalable iNKT Cell Therapy…

News

INKT ▲ +2.0% - MiNK Therapeutics, Inc.

CP $12.93▲ +2.0%Oct 2, 2026 · ThinkSabio Blog

$INKT - MiNK Therapeutics to Present Data on Treatment-Resistant Colorectal Cancer and Clearance of Senescent Tumor Cells and Fibroblasts at SITC 2026…

News

INKT ▼ -1.2% - MiNK Therapeutics, Inc.

CP $12.11▲ -1.2%Sep 30, 2026 · ThinkSabio Blog

$INKT - MiNK Therapeutics Selected for ARPA-H-Funded Initiative to Advance Room-Temperature Cell Therapy…